BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
2022 · Cell & Bioscience · 25 citations
https://doi.org/10.1186/s13578-022-00769-8
D
Di Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
665
Citations
13
h-index
22
i10-index
Di Wu is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Neuroblastoma Research and Treatments & Protein Degradation and Inhibitors. The author has an h-index of 13, co-authored 53 publications.
ORCID: 0000-0001-5623-5819Papers by this author
worksSAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
2022 · Cell Death and Disease · 16 citations
https://doi.org/10.1038/s41419-022-04624-z
CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma
2024 · Cancer Letters · 9 citations
https://doi.org/10.1016/j.canlet.2024.216882
The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma
2024 · BMC Cancer · 7 citations
https://doi.org/10.1186/s12885-024-12691-y
Screening of potentially active compounds against rheumatoid arthritis in the Juan-Bi decoction using systems pharmacology and animal experiments
2024 · Frontiers in Cell and Developmental Biology · 3 citations
https://doi.org/10.3389/fcell.2024.1396890
Wet pulverization combined with temperature cycling strategy for extraction of Stropharia rugosoannulata protein with attenuating hepatic steatosis on obese mice
2025 · Food Chemistry X · 3 citations
https://doi.org/10.1016/j.fochx.2025.102170
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat